VIRAL NEWS

BusinessNEWSVIRAL NEWS

The Trump drug price deal has emerged as one of the most significant healthcare policy developments in 2026, drawing both praise and criticism across the political spectrum. Announced as part of a broader push to reduce prescription drug costs, the agreement between former President Donald Trump’s administration and pharmaceutical giant Regeneron signals a renewed effort to tackle one of America’s most persistent economic concerns: high healthcare costs.

The deal, unveiled on April 23, 2026, aims to lower drug prices through a combination of government negotiation, market incentives,

Read More